Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2016. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138241000087114 | RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 71411000087112 | Rab RabAvert GSK | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 71431000087119 | RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 76851000087118 | Rage RabAvert GSK | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of inactivated whole Rabies lyssavirus Flury LEP strain grown in cellular line (substance) | true | Inferred relationship | Some | 1 | |
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product) | true | Inferred relationship | Some | ||
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Human rabies vaccine (substance) | false | Inferred relationship | Some | 1 | |
| RabAvert 2.5 international units per milliliter powder for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Rabies vaccine, human (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)
FHIR